Search found 72 matches
- Wed Jul 02, 2008 4:33 am
- Forum: Sativex
- Topic: Sativex in Europe
- Replies: 1
- Views: 3936
Sativex - Maker of cannabis-based medicines hit by disappoin
http://www.guardian.co.uk/business/2008/apr/08/pharmaceuticals.healthcare Maker of cannabis-based medicines hit by disappointing trial * Katie Allen * guardian.co.uk, * Tuesday April 8, 2008 * Article history GW Pharmaceuticals, which makes medicines based on cannabis, came out vociferously defendin...
- Tue Jun 17, 2008 9:08 am
- Forum: Regimens
- Topic: Combining beta interferon and atorvastatin may increase dise
- Replies: 0
- Views: 2698
Combining beta interferon and atorvastatin may increase dise
< shortened url > Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. From the MS Treatment and Research Center (G.B., I.A.), Minneapolis Clinic of Neurology, MN; Department of Neurology (B.C.), University of California San Francisco; and Department of Neu...
- Mon Jun 16, 2008 8:16 am
- Forum: Aimspro
- Topic: My wife is an Aimspro patient
- Replies: 4
- Views: 11590
Wonder drug lets Billy weigh anchor
http://www.portsmouth.co.uk/people/Wonder-drug-lets-Billy-weigh.4186622.jp Wonder drug lets Billy weigh anchor Published Date: 16 June 2008 By Matt Jackson Defence correspondent AT THE age of 64 most people are dreaming of a restful retirement, but thanks to a potential wonder drug Billy Edmiston is...
- Sat Apr 19, 2008 5:25 am
- Forum: Drug Pipeline
- Topic: Enkorten
- Replies: 24
- Views: 13807
Website for Farmacija - Enkorten
Found this which is in English http://www.farmacija.co.ba/ridfar.htm FAR404 Farmacija developed FAR404 as a novel compound with an immunomodulatory activity and enables cytoprotective effects and tissue/wound healing. It is a combination of two endogenous neuropeptides which originate from POMC horm...
- Tue Apr 15, 2008 2:29 pm
- Forum: Drug Pipeline
- Topic: Rituxan Joins List That Fail for Severe Form of MS
- Replies: 0
- Views: 2032
Rituxan Joins List That Fail for Severe Form of MS
Wall Street Journal April 15th 2008 http://online.wsj.com/article_email/SB120821848424614629-lMyQjAxMDI4MDE4NTIxMTU4Wj.html Rituxan Joins List of Treatments That Fail for Severe Form of MS By KEITH J. WINSTEIN April 15, 2008; Page B9 Rituxan, a top-selling drug from Genentech Inc. and Biogen Idec In...
- Thu Mar 27, 2008 4:40 am
- Forum: General Discussion
- Topic: Innate immune system research
- Replies: 1
- Views: 2125
A very interesting article, which reminded me that I had read something recently about the innate immune system and SF1019 which is a totally unapproved research product. The Immunosyn website which is a company involved in the development of SF1019 mentions this. http://www.immunosyn.com/prod_sf-10...
- Tue Mar 18, 2008 12:00 am
- Forum: Aimspro
- Topic: 17/03/08 - St George's Hospital Trial Judgement
- Replies: 0
- Views: 8535
17/03/08 - St George's Hospital Trial Judgement
http://www.davalinternational.com/index_files/news/news_article.php?nid=36 17/03/08 - St George's Hospital Trial Judgement The Board of Daval International Limited decided, in 2004, to terminate the first full-scale clinical trial of AIMSPRO at St George's Hospital, London. The Company had drawn on ...
- Sat Jan 26, 2008 6:42 am
- Forum: Aimspro
- Topic: Aimspro gets Approval for Phase IIB Trial
- Replies: 4
- Views: 10445
How Aimspro works. (Mechanism of action?)
http://www.proventus.org.uk/page81.html From the Proventus website. How Aimspro works. "Aimspro has been characterised biochemically and its mode of action has been determined. it is composed of a set of peptide that act to stimulate the releases and regulation of a molecular cascade that modul...
- Sat Jan 26, 2008 6:35 am
- Forum: Aimspro
- Topic: Aimspro gets Approval for Phase IIB Trial
- Replies: 4
- Views: 10445
Aimspro Bladder Trial - Recruits needed
Posted on the Proventus website http://www.proventus.org.uk/ Aimspro Bladder Trial - Recruits needed The trial for secondary progressive multiple sclerosis bladder function problems is to be conducted soon at the Whittington Hospital - Highgate - North London By Professor James Malone-Lee Interested...
- Sat Dec 08, 2007 1:56 pm
- Forum: Drug Pipeline
- Topic: Rituxan results from ECTRIMS
- Replies: 32
- Views: 12875
An interesting piece
http://www.businessweek.com/magazine/content/07_51/b4063000924207.htm It is still early days for Rituxan in autoimmune disease, but there have been some important milestones. On a Saturday in the summer of 2006, the MS research team gathered in a conference room to review early results of a key Ritu...
- Mon Nov 26, 2007 7:02 am
- Forum: Aimspro
- Topic: Aimspro gets Approval for Phase IIB Trial
- Replies: 4
- Views: 10445
Aimspro gets Approval for Phase IIB Trial
< shortened url > Daval International Limited Gains Approval for Phase IIB Trial of AIMSPRO(R) LONDON, November 26 /PRNewswire/ -- Daval International Limited, a UK private company, announces MHRA and IRB (Ethics Committee) approval of a London based Phase IIB trial of AIMSPRO(R), its hyperimmune ca...
- Sun Nov 04, 2007 1:10 pm
- Forum: General Discussion
- Topic: Article on research by Michael J Fox
- Replies: 4
- Views: 2607
Alan Osmonds website
Hi Pete, This might help from Alan Osmonds website. http://osmondms.com/ October 5, 2007 Today I was informed that Argyll Biotechnologies New Website is now available at: http://www.argyllbiotechnologies.com/ (link is above) You can learn more about the product that has helped me so much! It is call...